title: Inhibition of immune cell proliferation and cytokine production by lipoprotein-bound gangliosides.
abstract: We have analyzed the immunomodulatory effect of human melanoma gangliosides bound to serum lipoprotein fractions on normal human immune-competent cells in vitro. Total melanoma gangliosides in micelles inhibited proliferation of peripheral blood mononuclear cells stimulated by various mitogens, modulated lymphocyte surface molecules CD2, CD3, CD4, CD5 and CD8 and inhibited the production of interleukin-1 beta (IL-1 beta), tumor necrosis factor alpha (TNF alpha) and IL-6 by stimulated adherent cells. Most of these effects were abrogated in the presence of serum. Purified serum lipoprotein fractions were tested for their ability to allow or inhibit the immunomodulatory effects of gangliosides. Melanoma gangliosides bound to very-low-density lipoproteins (VLDL) were shown to be as potent modulators of the immune response in vitro as when they were presented to cells in the form of micelles. Gangliosides bound to low-density lipoproteins were less active and gangliosides bound to high-density lipoproteins or the lipoprotein-free fraction had no immunomodulatory effects. Given the fact that gangliosides are predominantly bound to lipoproteins in serum, we conclude that lipoproteins are important determinants of the immunomodulating potential of tumor gangliosides, and that the immunomodulatory effects of melanoma gangliosides observed in vitro may also occur in vivo.
authors.affiliation: INSERM U 218, Centre Léon Bérard, Lyon, France.
authors.forename: C
authors.initials: C
authors.lastname: Dumontet
authors.forename: A
authors.initials: A
authors.lastname: Rebbaa
authors.forename: J
authors.initials: J
authors.lastname: Bienvenu
authors.forename: J
authors.initials: J
authors.lastname: Portoukalian
mesh_terms: D015703:Antigens, CD / Q000276:immunology; D002478:Cells, Cultured; D016207:Cytokines / Q000096:biosynthesis*; D005732:Gangliosides / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D007375:Interleukin-1 / Q000096:biosynthesis; D015850:Interleukin-6 / Q000096:biosynthesis; D007963:Leukocytes, Mononuclear / Q000276:immunology*; D008074:Lipoproteins / Q000097:blood / Q000378:metabolism*; D008213:Lymphocyte Activation; D008545:Melanoma / Q000378:metabolism*; D008823:Micelles; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
chemical_list: D015703:Antigens, CD; D016207:Cytokines; D005732:Gangliosides; D007375:Interleukin-1; D015850:Interleukin-6; D008074:Lipoproteins; D008823:Micelles; D014409:Tumor Necrosis Factor-alpha